223 related articles for article (PubMed ID: 37355214)
1. Accelerating antibody discovery and design with artificial intelligence: Recent advances and prospects.
Bai G; Sun C; Guo Z; Wang Y; Zeng X; Su Y; Zhao Q; Ma B
Semin Cancer Biol; 2023 Oct; 95():13-24. PubMed ID: 37355214
[TBL] [Abstract][Full Text] [Related]
2. Computational and artificial intelligence-based methods for antibody development.
Kim J; McFee M; Fang Q; Abdin O; Kim PM
Trends Pharmacol Sci; 2023 Mar; 44(3):175-189. PubMed ID: 36669976
[TBL] [Abstract][Full Text] [Related]
3. Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery.
Wilman W; Wróbel S; Bielska W; Deszynski P; Dudzic P; Jaszczyszyn I; Kaniewski J; Młokosiewicz J; Rouyan A; Satława T; Kumar S; Greiff V; Krawczyk K
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830864
[TBL] [Abstract][Full Text] [Related]
4. Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.
Akbar R; Bashour H; Rawat P; Robert PA; Smorodina E; Cotet TS; Flem-Karlsen K; Frank R; Mehta BB; Vu MH; Zengin T; Gutierrez-Marcos J; Lund-Johansen F; Andersen JT; Greiff V
MAbs; 2022; 14(1):2008790. PubMed ID: 35293269
[TBL] [Abstract][Full Text] [Related]
5. Deep learning in preclinical antibody drug discovery and development.
Zhou Y; Huang Z; Li W; Wei J; Jiang Q; Yang W; Huang J
Methods; 2023 Oct; 218():57-71. PubMed ID: 37454742
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
7. How can we discover developable antibody-based biotherapeutics?
Bauer J; Rajagopal N; Gupta P; Gupta P; Nixon AE; Kumar S
Front Mol Biosci; 2023; 10():1221626. PubMed ID: 37609373
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
Qi X; Zhao Y; Qi Z; Hou S; Chen J
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398653
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation.
Narayanan H; Dingfelder F; Butté A; Lorenzen N; Sokolov M; Arosio P
Trends Pharmacol Sci; 2021 Mar; 42(3):151-165. PubMed ID: 33500170
[TBL] [Abstract][Full Text] [Related]
11. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
Zhang L; Tan J; Han D; Zhu H
Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence for compound pharmacokinetics prediction.
Obrezanova O
Curr Opin Struct Biol; 2023 Apr; 79():102546. PubMed ID: 36804676
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence in drug discovery: recent advances and future perspectives.
Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
[No Abstract] [Full Text] [Related]
14. Artificial intelligence for dementia drug discovery and trials optimization.
Doherty T; Yao Z; Khleifat AAL; Tantiangco H; Tamburin S; Albertyn C; Thakur L; Llewellyn DJ; Oxtoby NP; Lourida I; ; Ranson JM; Duce JA
Alzheimers Dement; 2023 Dec; 19(12):5922-5933. PubMed ID: 37587767
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence and machine learning applications in biopharmaceutical manufacturing.
Rathore AS; Nikita S; Thakur G; Mishra S
Trends Biotechnol; 2023 Apr; 41(4):497-510. PubMed ID: 36117026
[TBL] [Abstract][Full Text] [Related]
16. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
[TBL] [Abstract][Full Text] [Related]
17. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
Muller C; Rabal O; Diaz Gonzalez C
Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
[TBL] [Abstract][Full Text] [Related]
18. Artificial Intelligence in Accelerating Drug Discovery and Development.
Tripathi A; Misra K; Dhanuka R; Singh JP
Recent Pat Biotechnol; 2023; 17(1):9-23. PubMed ID: 35927896
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms.
Li G; Lin P; Wang K; Gu CC; Kusari S
Trends Cancer; 2022 Jan; 8(1):65-80. PubMed ID: 34750090
[TBL] [Abstract][Full Text] [Related]
20. Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.
Gautam V; Gaurav A; Masand N; Lee VS; Patil VM
Mol Divers; 2023 Apr; 27(2):959-985. PubMed ID: 35819579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
